自发纳米平台基于两性亡,用于精确的线粒体向光热疗法
Xin Wan1, Wensong Wang1, Yutian Zhou1
1Hubei Key Laboratory of Plasma Chemistry and Advanced Materials, School of Material Science and Engineering, Wuhan Institute of Technology, Wuhan 430205, China.
Molecular pharmaceutics
|February 15, 2024
概括
研究人员开发了一种新型的自传递纳米平台,用于精确的线粒体向光热疗法. 这种方法通过将药物直接输送到癌细胞线粒体中,增强了瘤细胞的破坏.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 癌症治疗 癌症治疗
背景情况:
- 针对线粒体的光热疗法提供了增强的瘤细胞杀伤.
- 准确地将治疗剂输送到线粒体仍然是一个重大挑战.
研究的目的:
- 开发一种自传递纳米平台,用于精确的线粒体向光热疗法.
- 通过向线粒体来增强瘤细胞的抑制.
主要方法:
- 将光热剂 IR780 封装在两性阿波化 KLA 中,形成纳米细胞 KI.
- 用瘤向聚合物HA覆盖KI,以创建HKI纳米平台.
- 利用CD44受体介导的内细胞和内体环境进行向释放和线粒体积累.
主要成果:
- 在HKI纳米平台成功准瘤细胞线粒体.
- 内分体的分解释放了KLA和IR780,使线粒体的精确引导和破坏成为可能.
- 在亚细胞器官水平上观察到增强的瘤细胞抑制.
结论:
- 开发的自传递纳米平台有效地将治疗剂传递给瘤细胞线粒体.
- 这种策略可以实现精确的线粒体破坏,提高光热疗法的疗效.
- 这种方法显示出改善癌症治疗结果的希望.
更多相关视频
10:16Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
Published on: February 8, 2017
7.6K
09:01Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Published on: May 22, 2020
3.1K
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
